Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

BACKGROUND: Following a clinical evaluation of deferasirox (Exjade(®)) it was concluded that, in addition to baseline body iron burden, ongoing transfusional iron intake should be considered when selecting doses. The 1-year EPIC study, the largest ever investigation conducted for an iron chelator, i...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Cappellini, Maria Domenica, Porter, John, El-Beshlawy, Amal, Li, Chi-Kong, Seymour, John F., Elalfy, Mohsen, Gattermann, Norbert, Giraudier, Stéphane, Lee, Jong-Wook, Chan, Lee Lee, Lin, Kai-Hsin, Rose, Christian, Taher, Ali, Thein, Swee Lay, Viprakasit, Vip, Habr, Dany, Domokos, Gabor, Roubert, Bernard, Kattamis, Antonis
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Ferrata Storti Foundation 2010
विषय:
Original Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2857545/
https://ncbi.nlm.nih.gov/pubmed/19951979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.014696
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन